SCM
XBI icon

SOL Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

SOL Capital Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,098
Closed -$1.96M – 308
2025
Q4 		$1.96M Sell
16,098
-467
-3% -$53.5K 0.18% 127
2025
Q3 		$1.66M Sell
16,565
-5,425
-25% -$489K 0.15% 137
2025
Q2 		$1.82M Sell
21,990
-8,052
-27% -$642K 0.18% 124
2025
Q1 		$2.44M Sell
30,042
-842
-3% -$75.3K 0.27% 96
2024
Q4 		$2.78M Sell
30,884
-1,221
-4% -$118K 0.31% 89
2024
Q3 		$3.17M Buy
32,105
+165
+0.5% +$16.2K 0.35% 78
2024
Q2 		$2.96M Buy
31,940
+174
+0.5% +$15.6K 0.36% 78
2024
Q1 		$3.01M Buy
31,766
+7,570
+31% +$702K 0.38% 80
2023
Q4 		$2.16M Buy
24,196
+13,865
+134% +$1.03M 0.29% 100
2023
Q3 		$754K Buy
10,331
+4,368
+73% +$349K 0.12% 168
2023
Q2 		$496K Buy
5,963
+1,078
+22% +$90.2K 0.08% 203
2023
Q1 		$372K Buy
4,885
+350
+8% +$29K 0.06% 228
2022
Q4 		$376K Buy
4,535
+895
+25% +$72.5K 0.07% 218
2022
Q3 		$289K Buy
3,640
+290
+9% +$24.4K 0.06% 225
2022
Q2 		$249K Buy
3,350
+600
+22% +$45K 0.05% 234
2022
Q1 		$247K Buy
2,750
+850
+45% +$78.5K 0.04% 243
2021
Q4 		$213K Buy
1,900
+200
+12% +$24.1K 0.04% 249
2021
Q3 		$214K Hold
1,700
– – 0.04% 237
2021
Q2 		$230K Hold
1,700
– – 0.05% 238
2021
Q1 		$231K Hold
1,700
– – 0.05% 225
2020
Q4 		$239K Buy
+1,700
New +$218K 0.06% 216

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

SOL Capital Management's XBI Position: Q1 2026 in Review

SOL Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 16,098 shares — an estimated $1.96M sold.

SOL Capital Management first reported a position in XBI in Q4 2020 and held it in 21 quarters. The position peaked at $3.17M in Q3 2024. 816 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • SOL Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
  • SOL Capital Management sold 16,098 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $1.96M.
  • SOL Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 21 quarters.
  • SOL Capital Management's State Street SPDR S&P Biotech ETF position peaked at $3.17M in Q3 2024.
  • 816 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on SOL Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.